Latest Breaking News On - Migraine family - Page 1 : comparemela.com

/CNW Telbec/ - AbbVie (NYSE: ABBV) announced today that Health Canada has approved QULIPTA (atogepant) for the prevention of episodic migraine (< 15 migraine.

Dominique touchetteHealth canadaInternational classification of headache disordersProduct monographAllergan aestheticsAbbvie canadaClassification committeeInternational headache societyInternational classificationHeadache disordersAccessed aprilMigraine family